Skip to content

The Steno Opti-Bolus-Timing Studies

Timing Insulin for Meals Using AID Systems

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07021690
Acronym
OBT Studies
Enrollment
40
Registered
2025-06-15
Start date
2025-06-30
Completion date
2027-06-30
Last updated
2025-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 Diabetes (T1D)

Keywords

AID system, bolus timing, Glycemic index

Brief summary

The project investigates the significance of the timing of insulin dosing for breakfast and lunch with an automated insulin pump and whether it matters if the meal primarily contains high or low glycemic index carbohydrates. We hypothesise that a bolus given 15 minutes before the meal will result in the best blood glucose levels after the meal, regardless of the type of carbohydrates. Participants will attend 6 experimental days over a maximum of 3 months, where they will be served either breakfast or lunch at the research site, depending on sub-study (breakfast or Lunch sub-study). Three different bolus timings will be tested, with either rapidly absorbed carbohydrates or slowly absorbed carbohydrates, in a randomized order for each participant. Participants will take insulin for the meal using the bolus calculator in the pump, either 15 minutes before, at the start of the meal, or 30 minutes after the meal. The development in sensor glucose will then be monitored for up to 4 hours after the meal.

Interventions

OTHERHigh glyceamic index meal

Meal sizes are standardized regarding the amount of carbohydrate, always 50 g. The composition of these meals focuses on selecting carbohydrates with high glycemic index.

OTHERLow glyceamic index meal

Meal sizes are standardized regarding the amount of carbohydrate, always 50 g. The composition of these meals focuses on selecting carbohydrates with low glycemic index.

Sponsors

Steno Diabetes Center Copenhagen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

the study contains two sub-studies: breakfast and lunch

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

Type 1 diabetes ≥ 3 years Age 18-70 years User of the MiniMed 780G for at least 3 months Use of Novorapid insulin in the pump (for a minimum of two weeks) TIR \> 70% for minimum of 14 days Use carbohydrate counting and bolus calculation Uploads insulin pump and CGM data to the Carelink Personal database Pump settings: carbohydrate ratio (300-500 rule), active insulin time of ≤ 3 hours and smartguard target glucose of 5.5 or 6.1 mmol/L

Exclusion criteria

Use of anti-diabetic medicine (other than insulin), corticosteroids or other drugs affecting glucose metabolism during the study period or within 4 weeks prior to study start Diagnosed with gastroparesis Females who are pregnant, breast-feeding Food allergies related to standardized meals Alcohol or drug abuse Inability to understand the individual information and to give informed consent. Current participation in another clinical trial that, in the judgment of the principal investigator, will compromise the study results

Design outcomes

Primary

MeasureTime frameDescription
Change in SG between three meal bolus delivery times for meals with two levels of glycemic indexFrom -15 min before the meal to 270 min after meal intakeThe primary objective is to compare the change in SG (from -15 min before the meal to the highest SG level measured during 0-270 min after start of meal intake) between three meal bolus delivery times for meals with two levels of glycemic index (GI) (high-GI and low-GI meals, respectively).

Secondary

MeasureTime frameDescription
Difference in amount of insulin given for autocorrections during the post-meal period between the three bolus methods for each type of meal.From -15 min before the meal to 270 min after meal intake
Distribution of Time Below Range (TBR)From -15 min before the meal to 270 min after meal intakeDistribution of TBR in the observation period of 4 hours and 45 minutes around the meal between the three bolus methods for each GI meal.
Difference in the number of Time Below Range events (with SG< 3.9 mmol/l)From -15 min before the meal to 270 min after meal intakeDifference in the number of Time Below Range (TBR) events (with SG\< 3.9 mmol/l) in the observation period of 4 hours and 45 minutes around the meal between the three bolus methods for each GI meal.
Area under the post-meal CGM-curveFrom -15 min before the meal to 270 min after meal intake
Distribution of Time In Tight target Range (TITR)From -15 min before the meal to 270 min after meal intakeDistribution of Time In Tight target Range (TITR), in the 4 hours and 45 minutes observation period around the meal between the three bolus methods for each GI meal.
Distribution of Time Above Range (TAR)From -15 min before the meal to 270 min after meal intakeDistribution of Time Above Range (TAR), in the 4 hours and 45 minutes observation period around the meal between the three bolus methods for each GI meal.
Number of hypoglycemia events (PG< 3.9 mmol/L )From -15 min before the meal to 270 min after meal intake
Distribution of Time In target Range (TIR)From -15 min before the meal to 270 min after meal intakeDistribution of Time In target Range (TIR) in the 4 hours and 45 minutes observation period around the meal between the three bolus methods for each GI meal.

Countries

Denmark

Contacts

Primary ContactKaren Rytter, RN, PhD
karen.rytter@regionh.dk+45 39680800
Backup ContactAjenthen Ranjan, MD, PhD
ajenthen.ranjan@regionh.dk+45 39680800

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026